Kazakhstan vs Kuwait: Access to anti-retroviral drugs, female
Kazakhstan
60.0%
in 2024
Kuwait
58.0%
in 2024
Kazakhstan rank
103rd
Kuwait rank
105th
Access to anti-retroviral drugs, female over time
- Kazakhstan
- Kuwait
How they compare
Kazakhstan currently reports 60.0% against 58.0% in Kuwait, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Kuwait ahead.
Kazakhstan ranks 103rd and Kuwait ranks 105th of 141 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 1 and Kuwait in 2.
Head to head by decade
| Decade | Kazakhstan | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.3% | 24.2% | 22.9% | Kuwait |
| 2010s | 21.3% | 33.3% | 12.0% | Kuwait |
| 2020s | 54.0% | 51.6% | 2.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Kazakhstan or Kuwait?
- Kazakhstan, at 60.0% against 58.0% in Kuwait as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Kazakhstan and Kuwait?
- 2.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Kuwait?
- 25 years are reported by both, from 2000 to 2024.
- How do Kazakhstan and Kuwait rank globally for access to anti-retroviral drugs, female?
- Kazakhstan ranks 103rd and Kuwait ranks 105th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.